featured – Page 19

FDA approves a new drug for symptoms of Huntington's disease

Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease

April 5, 2017

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

December 16, 2016

HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD

September 30, 2016

HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore

June 13, 2016

A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!

March 10, 2016

Stem cells and modeling Huntington's disease in our final Therapeutics Conference report

February 28, 2016

Researchers design a virus to more effectively deliver gene-silencing drugs throughout the brain.

February 1, 2016

Major Announcement: First HD patients treated with gene silencing drugs

October 19, 2015

GeM-HD identifies the first solid leads in the hunt for genetic variations that affect Huntington's disease onset

July 31, 2015

Variety in the HD gene’s on switch affects when symptoms arise.

May 29, 2015